U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727642) titled 'Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma' on July 22.
Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of different antiretroviral therapy (ART) strategies in adults with AIDS-related lymphoma (ARL) receiving anti-lymphoma treatment. The main questions it aims to answer are:
Does long-acting injectable ART, including albuvirtide (ABT) or long-acting cabotegravir/rilpivirine (CAB/RPV), improve virological suppression compared with oral ART during anti-lymphoma treatment? Do different ART strategies differ in immune recovery, virological failure, low-level vire...